Knowledge of medical specialists or medical specialist trainees about vaccinations not included in the official Certificate of Vaccination of Uruguay

  • Graciela Pérez Sartori Universidad de la República, Facultad de Medicina, Prof. Adj. Cátedra de Enfermedades Infecciosas
  • Paulina Brasó Universidad de la República, Facultad de Medicina, Especialista Enfermedades Infecciosas, Posgrado Cátedra de Enfermedades Infecciosas
  • Julio Medina Universidad de la República, Facultad de Medicina, Prof. Titular de Cátedra de Enfermedades Infecciosas
Keywords: ADULT, IMMUNIZATION COVERAGE, MISSED OPPORTUNITIES, URUGUAY

Abstract

Introduction: the burden of vaccine preventable diseases in adults is high. Immunization is an effective strategy to prevent these diseases. However, immunization coverage is low.

Several studies evidence that ignorance of indications and contraindications for vaccinations, and failure of a recommendation for immunization by physicians constitute the main barriers.

Objective: to learn about medical specialists’ or medical specialists trainees’ knowledge on “non-systematic” vaccinations (NSV, these are the vaccinations that are not included in the Certificate of vaccination) in adults and their behavior in connection with their recommendation.

Method: descriptive, transversal study by means of a self-administered survey to medical specialists at the Clínica Hospital, between September and November, 2014. Convenience sampling, non-probability.

Results: 127 physicians were interviewed, 12 specializations were covered. When asked to name NSV, 102 (80%) replied adequately, 116 (91%) state they recommend them and 84 (66%) declare they create a space to discuss vaccinations. Those who fail to do so argue they forget (49%) and they lack the time (38%). 45% of physicians provide adequate or appropriate information in regards to vaccination indications. 35% of physicians provide adequate or appropriate information in regards to vaccination contraindications. The most frequent mistake was to state inactive vaccines were contraindicated for immunocompromised patients or patients suffering from non-severe acute diseases. Specialists recommend NSV to the specific population they see in 35% of cases.

Conclusions: the specialists surveyed evidenced poor knowledge about indications and contraindications of NSV, since less than 50% of them were aware of indication and only 35% of them were aware of the contraindications. Only 35% of physicians were familiar with NSV specific indications in their area of specialization.

False contraindications were the most frequent mistake, leading to lost opportunities for immunization.

These findings point out the need to improve the training of physicians’/specialists’ to achieve better immunization coverage.

References

(1) Istúriz R, Celi de la Torre A. Generalidades. En: Istúriz R, ed. Vacunaciones de los adultos: manual práctico. Montevideo: API, 2013: 19-24.

(2) Organización Panamericana de la Salud. Temas de salud. Vacunación. Disponible en: http://www.paho.org [Consulta: 29 diciembre 2014.

(3) Hamborsky J, Kroger A, Wolfe S. Epidemiology and prevention of vaccine: preventable disease 2015. Disponible en: http://www.cdc.gov/vaccines/pubs/pinkbook/index.html. Consulta: 15 abril 2015.

(4) Istúriz R, Pérez Sartori G. Oportunidades perdidas de vacunación en los adultos. En: Istúriz R, ed. Vacunaciones de los adultos: manual práctico. Montevideo: API, 2013: 30-32.

(5) Poland GA, Shefer AM, Mc Cauley M, Webster PS, WhitleyWilliams PN, Peter G, et al. Standards for adult immunization practices. Am J Prev Med 2003; 25(2):144-50.

(6) Kim DK, Bridges CB, Harriman KH. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older - United States, 2015. MMWR Morb Mortal Wkly Rep 2015; 64(4):91-2.

(7) Takeda S, Hisano M, Komano H, Yamamoto H, Sago H, Yamaquchi K. Influenza vaccination during pregnancy and its usefulness to mothers and their young infants. J Infect Chemother 2015; 21(4):238-46.

(8) Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged < 12 months - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60(41):1424-6.

(9) Anselem O, Parat S, Théau A, Floret D, Tsatsaris V, Goffinet F, et al. Vaccination and pregnancy. Presse Med 2014; 43(6 Pt 1):715- 21.

(10) Nitsch-Osuch A, Korzeniewski K, Gawlak M, Życińska K, Wardyn K, Kuchar E. Epidemiological and clinical reasons for vaccination against pertussis and influenza in pregnant women. Adv Exp Med Biol 2015; 849:11-21.

(11) Stillo M, Carrillo Santisteve P, Lopalco PL. Safety of human papillomavirus vaccines: a review. Expert Opin Drug Saf. 2015; 14(5):697-712.

(12) Wicker S, Seale H, von Gierke L, Maltezou H. Vaccination of healthcare personnel: spotlight on groups with underlying conditions. Vaccine 2014; 32(32):4025-31.

(13) Campins M, Uriona S. Epidemiología general de las infecciones adquiridas por el personal sanitario. Inmunización del personal sanitario. Enferm Infecc Microbiol Clin 2014; 32(4):259-65.

(14) Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the inmunocompromised host. Clin Infect Dis 2014; 58(3):e44-100.

(15) Pérez Sartori G, Medina J. Vacunas en candidatos y receptores de trasplante de órgano sólido: un enfoque global. Carta Infectológica 2010; 9:20-2.

(16) Robin C, Beckerich F, Cordonnier C. Immunization in cancer patients: where we stand. Pharmacol Res 2015; 92:23-30.

(17) van Assen S, Elkayam O, Agmon-Levin N, Cervera R, Doran MF, Dougados M, et al. Vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun Rev 2011; 10:341-52.

(18) Perry LM, Winthrop KL, Curtis JR. Vaccinations for rheumatoid arthritis. Curr Rheumatol Rep 2014; 16(8):431.

(19) Vacunación antigripal 2012. En: MSP. Boletín Epidemiológico. Disponible en: http://www.msp.gub.uy/sites/default/files/archivos_adjuntos/Boletin%20Epidemiol%C3%B3gico%20agosto%202012.pdf. Consulta: 27 enero 2015.

(20) Pérez Sartori G, Ibarra A, Santa Cruz A, Fontes M, Archondo A, Dufrechou C. Oportunidades perdidas de vacunación en adultos usuarios de un hospital general. En: XV Congreso Panamericano de Infectología. Punta del Este; abril 2011.

(21) Sridhar S, Maleq N, Guillermet E, Colombini A, Gessner BD. A systematic literature review of missed opportunities for immunization in low- and middle-income countries. Vaccine 2014; 32(51):6870-9.

(22) Winston CA, Wortley PM, Lees KA. Factors associated with vaccination of medicare beneficiaries in five U.S. communities: Results from the racial and ethnic adult disparities in immunization initiative survey, 2003. J Am Geriatr Soc 2006; 54(2):303-10.

(23) Adult Immunization: knowledge, attitudes, and practices - DeKalb and Fulton Counties, Georgia, 1988. MMWR Morb Mortal Wkly Rep 1988; 37(43):657-61.

(24) Amaya G, Romero C, Veirano C, Barreto A, Pírez M. ¿Cuánto saben los médicos sobre vacunas no sistemáticas? En: IV Congreso Internacional de Infectología Pediátrica y Vacunas. Buenos Aires: marzo 2014.

(25) Comisión Honoraria para la Lucha Antituberculosa y Enfermedades Prevalentes. Programa Nacional Operativo de Inmunizaciones. Vacunación contra Influenza, año 2015. Disponible en: http://www.chlaep.org.uy/ Consulta: 4 julio 2015.

(26) Comisión Honoraria para la Lucha Antituberculosa y Enfermedades Prevalentes. Programa Nacional Operativo de Inmunizaciones. Vacunación contra Neumococo. Disponible en: http://www.chlaep.org.uy/ Consulta: 16 mayo 2015.

(27) Feris Iglesias J, Thormann Peynado M. Enfermedades neumocóccicas. Streptococcus pneumoniae, neumococo. En: Istúriz R, ed. Vacunaciones de los adultos: manual práctico. Montevideo: API, 2013:103-8.

(28) Uruguay. Ministerio de Salud Pública. Vacuna contra el virus del papiloma humano. Información para su ofrecimiento. Disponible en: http://msp.gub.uy/vacunas/index.html. Consulta: 22 julio 2015.

(29) Vázquez H. Virus del Papiloma Humano VPH. En: Istúriz R, ed. Vacunaciones de los adultos: manual práctico. Montevideo: API, 2013:132-8.

(30) Comisión Honoraria para la Lucha Antituberculosa y Enfermedades Prevalentes. Programa Nacional Operativo de Inmunizaciones. Vacunación contra dpaT. Disponible en: http://www.chlaep.org.uy/ Consulta: 22 junio 2015.

(31) Núñez B. Hepatitis B. VHB. En: Istúriz R, ed. Vacunaciones de los adultos: manual práctico. Montevideo: API, 2013:80-4.

(32) Comisión Honoraria para la Lucha Antituberculosa y Enfermedades Prevalentes. Programa Nacional Operativo de Inmunizaciones.Vacunación contra VHB. Disponible en: http://www.chlaep.org.uy/ Consulta: 22 junio 2015.

(33) Núñez B. Hepatitis A. VHA. En: Istúriz R, ed. Vacunaciones de los adultos: manual práctico. Montevideo: API, 2013:76-9.

(34) Mollinedo E, Muñoz G. Sarampión, rubéola y parotiditis. En: Istúriz R, ed. Vacunaciones de los adultos: manual práctico. Montevideo: API, 2013:121-7.

(35) Comisión Honoraria para la Lucha Antituberculosa y Enfermedades Prevalentes. Programa Nacional Operativo de Inmunizaciones. Vacunación contra SRP. Disponible en: http://www.chlaep.org.uy/ Consulta: 22 junio 2015.

(36) Rodríguez Taveras C. Varicela. Virus Varicela Zoster o VVZ. En: Istúriz R, ed. Vacunaciones de los adultos: manual práctico. Montevideo: API, 2013:128-31.

(37) Rodríguez Taveras C. Herpes Zoster. VVZ. Culebrilla. En: Istúriz R, ed. Vacunaciones de los adultos: manual práctico. Montevideo: API, 2013:85-8.

(38) Prieto J, Savio E. Haemophilus influenzae tipo B, Hib. En: Istúriz R, ed. Vacunaciones de los adultos: manual práctico. Montevideo: API, 2013:73-5.

(39) Celi de la Torre A. Meningitis Meningocóccica y meningococcemia. Neisseria meningitidis. En: Vacunaciones de los adultos: manual práctico. Montevideo: API, 2013:97-102.

(40) Nowalk M, Zimmerman R, Feghali J. Missed opportunities for adult immunization in diverse primary care office settings. Vaccine 2004; 22(25-26):3457-63.

(41) Úbeda M. Oportunidades perdidas de vacunación. Rev Pediatr Aten Primaria 2005; 7 (Supl 4):S43-54.

(42) Gentile A, Bakir J, Firpo V, Caruso M, Lución M, Abate H, et al. Esquemas atrasados de vacunación y oportunidades perdidas de vacunación en niños de hasta 24 meses: estudio multicéntrico. Arch Argent Pediatr 2011; 109(3):219-25.

(43) UdelaR. Facultad de Medicina. Nuevo plan de estudio 2008. Disponible en: http://www.bedelia.fmed.edu.uy/nuevoplandeestudios.html Consulta: 16 setiembre 2015.

(44) Arencibia Jiménez M, Navarro Gracia J, Delgado de los Reyes J , Pérez Torregrosa G, López Parra D , López García P . Oportunidades de vacunación antineumocócica. ¿Se puede hacer algo más en prevención? Arch Bronconeumol 2014; 50(3):93-8.

(45) Alvarez P, Bagnulo H, Dibarboure H. Análisis de las recomendaciones de vacunación antineumocócica en pacientes con Neumonia Aguda Comunitaria grave que ingresan a UCI. En: Congreso de la Asociación Panamericana de Infectología; 2009.

(46) Skull SA, Andrews RM, Byrnes GB, Kelly HA, Nolan TM, Brown GV, et al. Missed opportunities to vaccinate a cohort of hospitalized elderly with pneumococcal and influenza vaccines. Vaccine 2007; 25(28):5146-54.

(47) Kalaça S, Yalçin M, Simºek Yavuz S. Missed opportunities for tetanus vaccination in pregnant women and factor associated with seropositivity. Public Health 2004; 118(5): 377-82.

Published
2019-07-23
How to Cite
1.
Pérez Sartori G, Brasó P, Medina J. Knowledge of medical specialists or medical specialist trainees about vaccinations not included in the official Certificate of Vaccination of Uruguay. Rev. Méd. Urug. [Internet]. 2019Jul.23 [cited 2024Nov.25];33(1):34-6. Available from: http://www2.rmu.org.uy/ojsrmu311/index.php/rmu/article/view/130